Paper Details

  1. Home
  2. Paper Details

Non-Prescribed Substance Use during the First Month of Treatment by People Receiving Depot Buprenorphine for Opioid Use Disorder.

Author: NealeJoanne, ParkinStephen, StrangJohn

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Non-prescribed substance use (NPSU) during opioid use disorder (OUD) treatment can lead to treatment discontinuation. This study examined NPSU during the first month of treatment with depot buprenorphine. 17 out of 26 participants reported NPSU, mainly heroin and crack cocaine.
Paper Details　
Original Abstract of the Article :
<i>Background:</i> Non-prescribed substance use (NPSU) during the treatment of opioid use disorder (OUD) is a recognized phenomenon. The use of non-prescribed substances is associated with discontinuing treatment and drop-out can occur within the early weeks of treatment, before benefit from treatm...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/10826084.2023.2244064

データ提供：米国国立医学図書館（NLM）

Depot Buprenorphine: Navigating Non-Prescribed Substance Use in Opioid Use Disorder

Opioid use disorder (OUD) is a complex and challenging condition, and the use of non-prescribed substances (NPSU) is a common challenge during treatment. This study explored the phenomenon of NPSU in patients receiving depot buprenorphine, a long-acting medication for OUD. The researchers found that NPSU was prevalent during the first month of treatment, highlighting the need for careful management and individualized approaches to address this issue.

Understanding the Challenges: NPSU and Depot Buprenorphine

The study found that 17 out of 26 participants reported NPSU during the first month of depot buprenorphine treatment. The most common substances used were heroin, crack-cocaine, benzodiazepines, and cannabis. The participants reported various reasons for NPSU, including withdrawal symptoms, pain management, and experimentation. These findings underscore the complex interplay of factors contributing to NPSU in this population.

A Holistic Approach: Shared Decision-Making and Individualized Care

This study highlights the importance of addressing NPSU as part of comprehensive OUD treatment. The researchers emphasize the need for shared decision-making between providers and patients, establishing realistic treatment goals and strategies for managing NPSU. Individualized care plans that consider the unique needs and experiences of each patient are essential for promoting successful treatment outcomes and reducing the risk of relapse.

Dr.Camel's Conclusion

Just as camels navigate the desert with resilience and resourcefulness, patients with OUD face a challenging journey toward recovery. This study highlights the importance of addressing NPSU as part of a comprehensive treatment approach, emphasizing the need for shared decision-making and individualized care. By understanding the complex factors contributing to NPSU and providing tailored support, healthcare providers can help patients achieve lasting recovery and improve their quality of life.

Date :
  1. Date Completed 2023-09-29
  2. Date Revised 2023-10-09
Further Info :

Pubmed ID

37571999

DOI: Digital Object Identifier

10.1080/10826084.2023.2244064

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.